105 related articles for article (PubMed ID: 16101332)
1. Gastric carcinoma: 5 year experience of a single institute.
Sadighi S; Raafat J; Mohagheghi M; Meemary F
Asian Pac J Cancer Prev; 2005; 6(2):195-6. PubMed ID: 16101332
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
4. A reliable risk score for stage IV esophagogastric cancer.
Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
6. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
8. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution.
Wu HL; Tian Q; Peng CW; Liu SP; Li Y
Asian Pac J Cancer Prev; 2011; 12(12):3341-5. PubMed ID: 22471477
[TBL] [Abstract][Full Text] [Related]
9. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
12. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients.
Al-Moundhri MS; Al-Bahrani B; Burney IA; Nirmala V; Al-Madhani A; Al-Mawaly K; Al-Nabhani M; Thomas V; Ganguly SS; Grant CS
Oncology; 2006; 70(2):90-6. PubMed ID: 16601367
[TBL] [Abstract][Full Text] [Related]
13. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
[TBL] [Abstract][Full Text] [Related]
14. Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
Patel MI; Rhoads KF; Ma Y; Ford JM; Visser BC; Kunz PL; Fisher GA; Chang DT; Koong A; Norton JA; Poultsides GA
Ann Surg Oncol; 2013 May; 20(5):1631-8. PubMed ID: 23149854
[TBL] [Abstract][Full Text] [Related]
15. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
16. Survival of Patients with Stomach Cancer and its Determinants in Kurdistan.
Moradi G; Karimi K; Esmailnasab N; Roshani D
Asian Pac J Cancer Prev; 2016; 17(7):3243-8. PubMed ID: 27509957
[TBL] [Abstract][Full Text] [Related]
17. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
[TBL] [Abstract][Full Text] [Related]
18. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
20. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
